DESs (Drug-eluting stents) prove cost-effective in the long term
This article was originally published in Clinica
Executive Summary
Drug-eluting stents (DESs) may initially cost around three times more than the traditional bare metal variety but will prove cost-effective in the longer term, a US study has shown.